Shou Lin

Shou Lin


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in Clinica Chimica Acta
Verified
Journal Article
Closed access
XTXixiang Tang
Xixiang Tang
SLSuhua Li
Suhua Li
YWYina Wang
Yina Wang
MWManman Wang
Manman Wang
QYQiongli Yin
Qiongli Yin
YCYanming Chen
Yanming Chen

1 June 2015 in Diabetes Research and Clinical Practice
Verified
Journal Article
Open access
MWMan-Man Wang
Man-Man Wang
SLShou Lin
Shou Lin
YCYanming Chen
Yanming Chen
JSJiong Shu
Jiong Shu
HLHong-Yun Lu
Hong-Yun Lu
PMPan-Wei Mu
Pan-Wei Mu
This study compared the effects on glycaemic variability and glucose control between saxagliptin and acarbose as add-on therapies for aged T2DM inadequately controlled with metformin alone. The results showed that compared with acarbose-metformin, saxagliptin-metformin was more effective in glucose control with similar glycaemic variability.

19 September 2015 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
PDF file
LLLi Liu
Li Liu
DYDaizhi Yang
Daizhi Yang
YZYan Zhang
Yan Zhang
SLShou Lin
Shou Lin
XZXueying Zheng
Xueying Zheng
Jianping WengJianping Weng
Jianping Weng

19 October 2017 in The American Journal of the Medical Sciences
Verified
Journal Article
Closed access
PDF file
PLPing Li
Ping Li
SLShou Lin
Shou Lin
JCJinhui Cui
Jinhui Cui
LLLing Li
Ling Li
SZShuisheng Zhou
Shuisheng Zhou
JFJianhui Fan
Jianhui Fan

12 September 2018 in BMC Endocrine Disorders
Verified
Journal Article
Open access
PDF file
PLPing Li
Ping Li
SLShou Lin
Shou Lin
LLLing Li
Ling Li
JCJinhui Cui
Jinhui Cui
SZShuisheng Zhou
Shuisheng Zhou
JFJianhui Fan
Jianhui Fan
To investigate the effect of a mildly elevated thyroid-stimulating hormone (TSH) concentration between 2.5 and 4.0 mIU/L during the first trimester on pregnancy outcomes in thyroid peroxydase antibody (TPOAb)-negative pregnant women. A total of 1858 pregnant women who were TPOAb-negative before 13+ 6 gestational weeks, received regular prenatal services, and delivered in the third affiliated hospital of Sun Yat-Sen University were recruited from June 2016 to June 2017. Measurements of thyroid function (TSH, free T4 [FT4] and TPOAb) and adverse pregnancy outcomes were assessed and recorded. Among the 1858 study participants, the 97.5th percentile for TSH was 3.76 mIU/L, and 142 women (7.6%) had mildly elevated TSH levels between 2.5 and 4.0 mIU/L. No differences in the incidence of adverse pregnancy outcomes were observed between patients with a mildly elevated TSH level and those with a normal TSH level (< 2.5 mIU/L). A mildly elevated TSH concentration (2.5–4.0 mIU/L) during the first trimester of pregnancy in TPOAb-negative women was not associated with adverse pregnancy outcomes in our study population. Accordingly, it may be possible to raise the upper limit of the healthy TSH reference range for pregnant women.

23 November 2022 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
PLPing Li
Ping Li
JCJinhui Cui
Jinhui Cui
LLLing Li
Ling Li
XCXinjuan Chen
Xinjuan Chen
LOLiping Ouyang
Liping Ouyang
SLShou Lin
Shou Lin
Background: The association between isolated maternal hypothyroxinemia (IMH) and adverse pregnancy outcomes is still controversial. This study aimed to evaluate the association between IMH during the first trimester and adverse pregnancy outcomes in southern Chinese women. Methods: This was a hospital-based, retrospective cohort study. The records of 7051 women, including 1337 IMH women and 5714 euthyroid women who had a singleton pregnancy and accepted routine prenatal service at the Third Affiliated Hospital of Sun Yat-Sen University from January 2015 to September 2018, were extracted from the electronic medical records system in this study. Thyroid functions [thyroid-stimulating hormone (TSH), free thyroxine (fT4) and anti-thyroperoxidase autoantibody (TPO-Ab)] had to be measured before 13 weeks and 6 days of gestation. The chi-square test and multivariate logistic regression analysis were applied to evaluate the association between IMH during the first trimester and adverse pregnancy outcomes. Results: Prepregnancy obesity [prepregnancy body mass index (preBMI) ≥ 25 kg/m2] was found to be more common in the IMH group (11.2% vs. 6.1%) (P < 0.05). The prevalence of gestational diabetes mellitus (GDM), postpartum haemorrhage (PPH), macrosomia and large for gestational age (LGA) was higher in the IMH group. However, after using multivariate logistic regression analysis to adjust for confounders (maternal age, educational levels and preBMI), only LGA was shown to be associated with an increased risk in IMH women [adjusted OR: 1.27 (95% CI 1.044–1.566)]. The prevalence of preterm delivery (either < 37 or < 34 weeks), gestational hypertension, preeclampsia, placenta previa, placental abruption, premature rupture of membrane (PROM), intrauterine growth restriction (IUGR), polyhydramnios, stillbirth, small for gestational age (SGA) and low Apgar score did not increase. Conclusion: IMH during the first trimester did not increase any risk of adverse pregnancy outcomes in southern Chinese women except LGA.